Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
Yunpeng Yang(State Key Laboratory of Oncology in South China), Zhehai Wang(Shandong First Medical University), Jian Fang(Peking University Cancer Hospital), Qitao Yu(Tumor Hospital of Guangxi Medical University), Baohui Han(Shanghai Chest Hospital), Shundong Cang(Zhengzhou University), Gongyan Chen(Third Affiliated Hospital of Harbin Medical University), Xiaodong Mei(Anhui Provincial Hospital), Zhixiong Yang(Guangdong Medical College), Rui Ma(Liaoning Cancer Hospital & Institute), Minghong Bi(First Affiliated Hospital of Bengbu Medical College), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Jianying Zhou(Zhejiang University), Baolan Li(Capital Medical University), Yong Song(Nanjing General Hospital of Nanjing Military Command), Jifeng Feng(Jiangsu Cancer Hospital), Juan Li(Sichuan Cancer Hospital), Zhiyong He(Fujian Provincial Cancer Hospital), Rui Zhou(Central South University), Weimin Li(West China Hospital of Sichuan University), You Lü(Sichuan University), Yingyi Wang(Peking Union Medical College Hospital), Lijun Wang(Hebei Medical University), Nong Yang(Hunan Cancer Hospital), Yan Zhang(First Hospital of Shijiazhuang), Zhuang Yu(Affiliated Hospital of Qingdao University), Yanqiu Zhao(Zhengzhou University), Conghua Xie(Zhongnan Hospital of Wuhan University), Ying Cheng(Jilin Province Tumor Hospital), Hui Zhou, Shuyan Wang, Donglei Zhu, Wen Zhang, Li Zhang(Sun Yat-sen University)
Cited by 389Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis